Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Hessen, Erika; b; * | Nordlund, Artoc | Stålhammar, Jacobc | Eckerström, Mariec | Bjerke, Mariac | Eckerström, Carlc | Göthlin, Mattiasc | Fladby, Tormoda; d | Reinvang, Ivarb | Wallin, Andersc
Affiliations: [a] Department of Neurology, Akershus University Hospital, Oslo, Norway | [b] Clinical Neuroscience Research Group, Department of Psychology, University of Oslo, Oslo, Norway | [c] Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg, University, Mölndal, Sweden | [d] Faculty of Medicine, University of Oslo, Oslo, Norway
Correspondence: [*] Correspondence to: Erik Hessen, Department of Neurology, Akershus University Hospital, Norway. Tel.: +47 92097373; erik.hessen@nevropsykologi.no
Abstract: Background: There is a need to find very early markers for pre-clinical Alzheimer’s disease as interventions early in the disease process are thought to be most effective. Objective: The present study aimed to address the potential relation between cerebrospinal fluid (CSF) biomarkers and reduced cognitive function in a relatively young cohort of memory clinic patients with subjective cognitive decline. Methods: 122 patients (mean age 63 years) with subjective cognitive decline were recruited from two university memory clinics and followed for two years. Results: The main finding was that the subgroup with objective memory decline during the study period had significantly higher T-tau at baseline than the group with improved memory. Baseline CSF variables showed a trend toward more pathological values in the patients with memory decline compared to those who improved or remained stable. The baseline memory score of those who declined was significantly better than the baseline score of those who improved over two years. The general trend for the whole group was improved memory and executive test scores. There were no differences in cognitive scores based on CSF quartiles at baseline, nor were there differences in cognitive outcome for patients with early amnestic mild cognitive impairment versus average cognitive function at baseline. Conclusions: The main finding that T-tau rather than amyloid-β was associated with memory decline do not support the prevailing opinion about the chain of events assumed to take place in Alzheimer’s disease. In addition, memory decline was not associated with poor baseline memory score. Thus, a memory cut-off indicating low baseline memory would not would have identified the declining group.
Keywords: Cerebrospinal fluid biomarkers, early amnestic MCI, memory decline, mild cognitive impairment (MCI), pre-clinical AD, pre-clinical dementia, subjective cognitive decline, T-tau
DOI: 10.3233/JAD-150109
Journal: Journal of Alzheimer's Disease, vol. 47, no. 3, pp. 619-628, 2015
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl